Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin and memantine for pendular nystagmus in multiple sclerosis or oculopalatal tremor
2014-005548-17Phase 2Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of gabapentin and memantine in pendular nystagmus, multiple sclerosis (MS) and Oculopalatal tremor (OPT) (4 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Ophthalmic examination and best corrected visual acuity. Started Jun 2015; status: completed.
02
Drugs
gabapentinmemantine
03
Conditions
pendular nystagmusmultiple sclerosis (MS)Oculopalatal tremor (OPT)
Beyond the preview
Go deeper on 2014-005548-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005548-17.